TickerFacts.

A business in context

BIVI research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-07 · 8016 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. DEF 14A · Proxy statement

    Report date 2026-09-28 · 0001520138-26-000395

  2. 8-K · Current report

    Report date 2026-09-11 · 0001520138-26-000391 · Items 1.01,9.01

  3. 4 · Ownership change

    Report date 2026-08-28 · 0001520138-26-000383

  4. 4 · Ownership change

    Report date 2026-08-28 · 0001520138-26-000382

  5. 4 · Ownership change

    Report date 2026-08-28 · 0001520138-26-000379

  6. 4 · Ownership change

    Report date 2026-08-27 · 0001520138-26-000378

  7. 10-K · Annual report

    Report date 2026-06-30 · 0001520138-26-000332

  8. 8-K · Current report

    Report date 2026-08-06 · 0001520138-26-000312 · Items 7.01,9.01

  9. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001520138-26-000154

  10. 10-Q · Quarterly report

    Report date 2025-12-31 · 0001520138-26-000052

  11. 4 · Ownership change

    Report date 2026-01-05 · 0001520138-26-000024

  12. 4 · Ownership change

    Report date 2026-01-05 · 0001520138-26-000023

  13. 4 · Ownership change

    Report date 2026-01-05 · 0001520138-26-000022

  14. 4 · Ownership change

    Report date 2026-01-05 · 0001520138-26-000021

  15. 8-K · Current report

    Report date 2025-11-10 · 0001520138-25-000352 · Items 5.02,9.01

  16. 8-K · Current report

    Report date 2025-11-10 · 0001520138-25-000347 · Items 5.07

  17. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001520138-25-000343

  18. DEF 14A · Proxy statement

    Report date 2025-09-25 · 0001520138-25-000287

  19. 10-K · Annual report

    Report date 2025-06-30 · 0001520138-25-000268

  20. 8-K · Current report

    Report date 2025-08-07 · 0001520138-25-000249 · Items 1.01,3.02,7.01,9.01

  21. 8-K · Current report

    Report date 2025-07-17 · 0001520138-25-000223 · Items 5.02,7.01,9.01

  22. 8-K · Current report

    Report date 2025-06-26 · 0001520138-25-000190 · Items 3.03

  23. 8-K · Current report

    Report date 2025-06-23 · 0001520138-25-000185 · Items 5.07

  24. DEF 14A · Proxy statement

    Report date 2025-06-02 · 0001520138-25-000166

  25. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001520138-25-000144

  26. 8-K · Current report

    Report date 2025-03-28 · 0001520138-25-000089 · Items 5.02

  27. 10-Q · Quarterly report

    Report date 2024-12-31 · 0001520138-25-000056

  28. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001520138-24-000425

  29. 8-K · Current report

    Report date 2024-11-07 · 0001520138-24-000410 · Items 5.07

  30. 8-K · Current report

    Report date 2024-10-28 · 0001520138-24-000404 · Items 7.01,8.01,9.01

  31. 8-K · Current report

    Report date 2024-10-28 · 0001520138-24-000400 · Items 1.01,3.02,7.01,9.01

  32. SC 13G · Ownership disclosure

    0001753926-24-001767

  33. 8-K · Current report

    Report date 2024-10-23 · 0001520138-24-000387 · Items 7.01,8.01,9.01

  34. 8-K · Current report

    Report date 2024-10-23 · 0001520138-24-000379 · Items 1.01,3.02,7.01,9.01

  35. 8-K · Current report

    Report date 2024-10-22 · 0001520138-24-000376 · Items 7.01,8.01,9.01

  36. 8-K · Current report

    Report date 2024-10-21 · 0001520138-24-000372 · Items 1.01,3.02,7.01,9.01

  37. 10-K · Annual report

    Report date 2024-06-30 · 0001520138-24-000324

  38. DEF 14A · Proxy statement

    Report date 2024-09-27 · 0001520138-24-000322

  39. 8-K · Current report

    Report date 2024-09-25 · 0001520138-24-000320 · Items 7.01,8.01,9.01

  40. 8-K/A · Current report

    Report date 2024-09-23 · 0001520138-24-000313 · Items 9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

0 matching transaction rows.

No matching transaction rows in the covered quarter. This does not establish that no insider transactions occurred.

Identity & relationships

Wikidata structured data · retrieved 2026-10-07 · 1614 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001580149BIOVIE INC.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-07 · 1179 checked identities; 0 unavailable records

Search names and former names
  • NANOANTIBIOTICS, INC. · former SEC name · 2013-07-02 to 2016-07-22

Revenue in constant purchasing power

USD revenue expressed in 2026-08 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

No USD annual revenue periods with complete CPI coverage are available. Non-USD statements are not converted with U.S. CPI.

Bureau of Labor Statistics · retrieved 2026-10-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗